EN
HI
Summary
As of 21 Oct, 2026, Tatva Chintan Pharma Chem stock price is ₹1913.5. During the trading session, the stock has moved between an intraday low of ₹1892.00 and an intraday high of ₹2113.60. Over the last 52 weeks, Tatva Chintan Pharma Chem has traded between ₹1044.10 and ₹2113.60.
The stock has recorded a trading volume of 6,60,308 shares,. Its Average Traded Price (ATP) is ₹1976.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 4 @ ₹1913.50.
Tatva Chintan Pharma Chem has an upper circuit limit of ₹2284.00 and a lower circuit limit of ₹1522.80. The total value traded stands at ₹130.54 CR, and the delivery percentage for the day is 37.95%.
The stock is currently traded with a market lot size of 1. Tatva Chintan Pharma Chem also offers a dividend yield of 0.11%.
Tatva Chintan Pharma Chem Share Price Chart
Tatva Chintan Pharma Chem Share Key Metrics
Volume
6.60 L
Market Cap
4452.44 CR
LTQ@LTP
4@1913.50
ATP
1976.96
Var Margin
100 %
Circuit Range
1522.8-2284
Delivery %
37.95 %
Value
130.54 CR
ASM/GSM
No
Market Lot
1
Tatva Chintan Pharma Chem Fundamentals
P/E Ratio
70.64
P/B Ratio
5.46
Div. Yield
0.11
Sector P/E
53.37
Sector P/B
2.76
Sec. Div. Yield
0.59
Tatva Chintan Pharma Chem Resistance and Support
Pivot 1914.6
Resistance
First Resistance
1981.7
Second Resistance
2060
Third Resistance
2127.1
Support
First Support
1836.3
Second Support
1769.2
Third Support
1690.9
Tatva Chintan Pharma Chem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Oct 21 2026 | 2044 | 1913.5 | 0.53% | 2113.6 | 1892 |
| Mon Oct 19 2026 | 1944 | 1903.4 | -2.09% | 1992.9 | 1847.5 |
| Fri Oct 16 2026 | 1930 | 1944 | 0.17% | 1973.4 | 1900 |
Tatva Chintan Pharma Chem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-19 | Quarterly Results |
| 2026-07-17 | Quarterly Results |
| 2026-05-16 | Audited Results & Final Dividend |
| 2026-01-21 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
| 2025-05-02 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Tatva Chintan Pharma Chem News
Tatva Chintan Pharma Chem Ltd - 543321 - Updated Investor Presentation
Tatva Chintan released an updated investor presentation correcting its H1 FY27 RoE to 6.3% (from 2.6%) and Debt/EBITDA to 1.16x. The company reported a 76% YoY jump in Q2 FY27 revenue to Rs.217.3 crores and a 116% YoY increase in PAT to Rs.21.5 crores.
Oct 19 2026 21:16:04
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 19.10.2026
Tatva Chintan reported Q2 FY27 cons. total income of ₹219.07 crore and a net profit of ₹21.45 crore, reflecting a 116.2% YoY increase. The board of directors approved these financial results on October 19, 2026.
Oct 19 2026 15:59:19
Read More
Tatva Chintan Pharma Chem Management
| Name | Position |
|---|---|
| Ishwar Nayi | Company Secretary & Compliance Officer |
| Chintan Nitinkumar Shah | Chairman & Managing Director |
Tatva Chintan Pharma Chem Similar Stocks
Rashtriya Chemicals and Fertilizers Ltd.
99.65
-2.95 (2.88%)
Prince Pipes and Fittings Ltd.
268.25
-9.00 (3.25%)
Indigo Paints Ltd.
1004.80
-34.10 (3.28%)
Laxmi Organic Industries Ltd.
160.08
-11.06 (6.46%)
Foseco India Ltd.
6000.00
-225.50 (3.62%)
Prasol Chemicals Ltd.
701.60
-25.50 (3.51%)
Yasho Industries Ltd.
3386.10
-147.50 (4.17%)
Epigral Ltd.
938.70
-42.20 (4.30%)
Gujarat Alkalies And Chemicals Ltd.
553.85
-20.50 (3.57%)
Tatva Chintan Pharma Chem FAQs
The Buying Price of Tatva Chintan Pharma Chem share is 1913.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Tatva Chintan Pharma Chem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Tatva Chintan Pharma Chem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Tatva Chintan Pharma Chem shares is 70.64. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Tatva Chintan Pharma Chem shares is 5.46. Useful to assess the stock's value relative to its book value.
To assess Tatva Chintan Pharma Chem’s valuation compare Sector P/E, P/B which are 53.37 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of Tatva Chintan Pharma Chem is 4452.44 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Tatva Chintan Pharma Chem share price is 2113.60 & 1044.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Tatva Chintan Pharma Chem belongs to the Chemicals sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in TATVA
